Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome

Affiliations

• ¹ Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy.
• ² Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA.
• ³ Laboratory of Health and Environment, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Rome, Italy.
• ⁴ Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy. melino@uniroma2.it.
• ⁵ Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy. m.agostini@med.uniroma2.it.